Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Conditions
Endometrial Cancer · Endometrioid Tumor · Cancer · Tumor · Recurrent Endometrial Carcinoma · Endometrioid Endometrial Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Michael Birrer, MD, PhD, Little Rock, Arkansas, United States
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
Contact: Principal Investigator (Brian Slomovitz, MD)Women's Cancer Center of Nevada, Las Vegas, Nevada, United States
Contact: Principal Investigator (Nicola M Spirtos, MD)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Angela Green, MD)Levine Cancer Institute, Charlotte, North Carolina, United States
Contact: Study coordinator (Leah J Wilson, BS, RN, OCN) · leah.j.wilson@atriumhealth.org · 980-442-2333Contact: Principal Investigator (Allison M Puechi, MD)Oklahoma University Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Lauren Dockery, MD)Women & Infants Hospital, Providence, Rhode Island, United States
Contact: Principal Investigator (Cara Mathews, MD)Texas Oncology - Tyler, Tyler, Texas, United States
Contact: Principal Investigator (Anna Priebe, MD)Swedish Cancer Institute, Seattle, Washington, United States
Contact: Principal Investigator (Fernanda Musa, MD)
Study leads
Willis Navarro, MD
Study Director
Aadi Bioscience